(Press-News.org) Anti-rheumatic drugs used for rheumatoid arthritis might prevent the development of autoimmune thyroid disease, according to a new observational study by researchers from Karolinska Institutet published in the Journal of Internal Medicine.
It is well known that patients with rheumatoid arthritis are at increased risk of autoimmune thyroid diseases such as Hashimoto's disease and Graves' disease. While patients with RA are usually treated with immunomodulatory drugs that affect the immune system, such drugs are rarely used in autoimmune thyroid diseases. Instead, such patients are treated with thyroid hormone to compensate for the changes in normal thyroid function that accompany autoimmune thyroid disease.
The researchers in the current study wanted to investigate whether immunomodulatory drugs that reduce inflammation in the joints of patients with RA might also reduce the risk of these patients developing autoimmune thyroid disease. Previous studies in mice suggest that so-called DMARDs, a type of immune-modulatory drugs used to treat rheumatoid arthritis, can reduce inflammation in the thyroid gland. Still, knowledge of whether this effect also applies to humans is limited, according to the research team.
The researchers used data between 2006 and 2018 on over 13,000 patients with rheumatoid arthritis and their treatment, as well as data from over 63,000 individuals in a matched control group without rheumatoid arthritis.
The researchers found that the risk of developing an autoimmune thyroid disease among RA patients was lower after their onset of the rheumatic disease than before diagnosis.
The most pronounced reduction in the risk of autoimmune thyroid disease was seen in patients with rheumatoid arthritis treated with immunomodulatory drugs or 'biological DMARDs'. In these patients, the risk of autoimmune thyroid disease was 46 percent lower than in the control group without rheumatoid arthritis.
"These results support the hypothesis that certain types of immunomodulatory drugs could have a preventive effect on autoimmune thyroid disease," says Kristin Waldenlind, researcher at the Department of Medicine, Solna, Division of Clinical Epidemiology, Karolinska Institutet, specialist in rheumatology at Karolinska University Hospital and first author of the study. She continues:
"Our results do not prove that it is the treatment with immunomodulatory drugs that led to the reduced risk of autoimmune thyroid disease, but provide support for this hypothesis. The results, if they can be replicated in further studies, open up the possibility of studying more directly in clinical trials whether the immunomodulatory drugs currently used for rheumatoid arthritis could also be used for the early treatment of autoimmune thyroid disease, i.e. for new areas of use of these drugs, known as drug repurposing.
The Swedish Research Council, the Swedish Heart-Lung Foundation and Vinnova mainly financed the study.
Publication: 'Disease-modifying antirheumatic drugs and risk of thyroxine-treated autoimmune thyroid disease in patients with rheumatoid arthritis', Kristin Waldenlind, Bénédicte Delcoigne, Saedis Saevarsdottir, Johan Askling, Journal of Internal Medicine, online November 22, 2023, doi: 10.1111/joim.13743
END
Anti-rheumatic drugs could prevent thyroid disease
2023-11-22
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Does spaceflight increase men’s risk of erectile dysfunction?
2023-11-22
During missions into space, astronauts are exposed to high levels of galactic cosmic radiation and weightlessness. Simulation experiments in male rats indicated that these aspects of spaceflight can negatively affect vascular tissues relevant to erectile dysfunction, even after a period of long-term recovery.
The research, which is published in The FASEB Journal, indicated that vascular alterations are induced by relatively low doses of galactic cosmic radiation and to a lesser extent simulated weightlessness, primarily through increases in oxidative stress. Treatment with different antioxidants could counter some of these ...
What are the effects of workforce automation across race and gender in the United States?
2023-11-22
Advances in areas such as robotics and artificial intelligence enable the automation of a range of occupational tasks, leading to fundamental changes in the nature of work. New research published in The American Journal of Economics and Sociology indicates that the effects of job automation vary across race and gender, and without targeted interventions, will likely result in increasing inequality.
The research analyzes two distinct measures of automation job displacement risk for more than 1.4 million Americans across 385 occupations. The findings show that the intersection of race and gender has a significant effect on automation risks. For example, ...
Has the COVID-19 pandemic compromised bone health?
2023-11-22
Results from a study published in the American Journal of Human Biology suggest that the COVID-19 pandemic has had negative effects on bone tissue—including both bone mineral density in the forearm and total bone mineral content.
The study by investigators at Comenius University, in Slovakia, included 387 young adults whose bone health measurements were taken prior to the COVID-19 pandemic and 386 whose measurements were taken from September 2020 to November 2022 during the pandemic. Individuals participated in the study only once, either before or during the pandemic.
Certain lifestyle changes during the pandemic may have contributed ...
Does stem cell transplantation benefit patients with knee osteoarthritis?
2023-11-22
Cell therapy represents a potential regenerative treatment for osteoarthritis. A recent analysis of all relevant published studies indicates that stem cell transplantation from different sources is effective for treating knee osteoarthritis, the most prevalent chronic joint disease.
The review and meta-analysis, which is published in the Journal of Orthopaedic Research, included 16 studies involving 875 patients with knee osteoarthritis (441 in the stem cell transplantation group and 434 in the control group). Stem cell treatment was associated with significant reductions in patient-reported pain from the third month onwards. The most significant pain relief at different postoperative months ...
Can sound stimulation lessen long-term concussion symptoms?
2023-11-22
New research indicates that acoustic stimulation of the brain may ease persistent symptoms in individuals who experienced mild traumatic brain injury in the past.
The study, which is published in Annals of Clinical and Translational Neurology, included 106 military service members, veterans, or their spouses with persistent symptoms after mild traumatic brain injury 3 months to 10 years ago. Participants were randomized 1:1 to receive 10 sessions of engineered tones linked to brainwaves (intervention), or random ...
New partnership between ResearchGate and Pensoft to drive readership and visibility of open access journals
2023-11-22
ResearchGate, the professional network for researchers, and Pensoft, an independent open access academic publisher known worldwide for its cutting-edge publishing tools and workflows, today announced a new partnership that will see a set of Pensoft’s open access journals increase their reach and visibility through ResearchGate – increasing access and engagement with its 25 million researcher members.
Pensoft is a fully open access publisher, providing high-quality end-to-end services to its own and third-party scientific journals via its in-house developed scholarly publishing platform ARPHA.
As part of this new partnership, ...
Experts urge a united global vision, definitions and targets for ‘responsible sourcing’ of minerals needed for green transition
2023-11-22
Experts have delivered a sweeping prescription to governments, civil society and industry for a globally coordinated approach to the responsible sourcing of raw materials needed to achieve a circular green economy.
In a report, the four-year EU-funded RE-SOURCING project proposes adopting the global vision of a circular economy and reduced resource consumption by 2050 and outlines a series of interim milestones and targets for three key industrial sectors: renewable energy, mobility, and electric and electronic equipment.
The report (at https://bit.ly/3uqXlqT from ...
Rise in people discovered dead and decomposed raises concerns
2023-11-22
An exploratory study has raised concerns about the increasing number of people in England and Wales whose bodies are discovered so late that they have decomposed.
The study, published in the Journal of the Royal Society of Medicine, has highlighted potential links between growing isolation and such deaths, even before the COVID-19 pandemic.
The study was authored by a team led by Dr Lucinda Hiam of the University of Oxford and including histopathology registrar Dr Theodore Estrin-Serlui of Imperial College NHS Healthcare Trust.
The researchers analysed data from the Office for ...
Obesity may not be the only factor to link ultra-processed foods to higher risk of mouth, throat and oesophagus cancers
2023-11-22
Eating more ultra-processed foods (UPFs) may be associated with a higher risk of developing cancers of upper aerodigestive tract (including the mouth, throat and oesophagus), according to a new study led by researchers from the University of Bristol and the International Agency for Research on Cancer (IARC). The authors of this international study, which analysed diet and lifestyle data on 450,111 adults who were followed for approximately 14 years, say obesity associated with the consumption of UPFs may not be the only factor to blame. The study is published today [22 November] in the European Journal of Nutrition.
Several ...
Immunotherapy drug is well tolerated in lung cancer patients with limited physical function, study suggests
2023-11-22
For patients with advanced or metastatic non-small cell lung cancer (NSCLC) and limited performance status, an immune checkpoint inhibitor drug called durvalumab is safe and may benefit overall survival, according to a new eClinicalMedicine study by UPMC Hillman Cancer Center researchers.
Performance status, a measure of a patient’s physical function and ability to perform daily activities, is often assessed with the Eastern Cooperative Oncology Group (ECOG) score on a scale of 0 to 5. Higher values describe patients who spend more time confined to a bed or chair and have less ability to care for themselves. Many clinical ...